Jackson v. Personal Representative of Donald Comb

CourtDistrict Court, D. Massachusetts
DecidedAugust 7, 2025
Docket1:23-cv-12208
StatusUnknown

This text of Jackson v. Personal Representative of Donald Comb (Jackson v. Personal Representative of Donald Comb) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jackson v. Personal Representative of Donald Comb, (D. Mass. 2025).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

MELISSA JACKSON and MARTA MEDA, Plaintiffs, v. NEW ENGLAND BIOLABS, INC.; PERSONAL REPRESENTATIVE OF DONALD COMB; JAMES V. ELLARD; Civil Action No. 1:23-cv-12208-RGS RICHARD IRELAND; COMMITTEE OF NEW ENGLAND BIOLABS, INC. ORDER GRANTING FINAL EMPLOYEES’ STOCK OWNERSHIP PLAN, APPROVAL OF CLASS ACTION SETTLEMENT Defendants, and NEW ENGLAND BIOLABS, INC. NON- VOTING STOCK OWNERSHIP PLAN, Nominal Defendant

This case came before the Court on Plaintiffs Melissa Jackson and Marta Meda’s Unopposed Motion for Final Approval of Class Action Settlement (ECF No. 100). Based upon the Court’s review of the motion and the memorandum submitted in support thereof, the Court GRANTS the Motion for Final Approval, finally certify the Class, finally approve the Settlement, and find as

follows: 1. Class Certification. The Class! as defined by the Court’s Order dated April 21, 2025 (ECE No, 94) (the “Preliminary Approval Order’) is finally certified for settlement purposes under Rule 23(a) and Rule 23(b)(1) and (b)(2) as follows: All participants in the New England BioLabs Non-Voting Stock Ownership Plan whose NEB stock in their Plan account was liquidated (in whole or in part) between September 29, 2017 and December 31, 2021 — including all participants to whom NEB shares were distributed in kind (i.e. in the form of physical share certificates) between September 29, 2017 and September 30, 2019 and which were subsequently repurchased by NEB or the Plan before December 31, 2020 — and the beneficiaries _ of such participants, except the Excluded Persons. “Excluded Persons” means the following persons who are excluded from the Class: (a) Defendants, (b) officers and directors of New England Biolabs, Inc., (c) any fiduciaries of the Plan at any time during September 2017 and December 30, 2021, (d) the beneficiaries of such persons or (e) the immediate family members of any of the foregoing, (f) any participant who previously settled claims alleged in the Amended Complaint, and (g) the legal representatives, successors, and assigns of any such excluded persons. 2. Appointment of Class Counsel. Pursuant to Rules 23(a)(4) and 23(g), the Court confirms its prior appointment of Melissa Jackson and Marta Meda as representatives of the Class and its prior appointment of R. Joseph Barton (of The Barton Firm LLP) and Jonathan Feigenbaum as Co-Lead Class Counsel. 3. Class Notice. The distribution of the Notice of Class Action Settlement was in accordance with the terms of the Settlement and the Preliminary Approval Order. ECF No, 96-1 { 7. The distribution of the Class notice also (a) constituted the best practicable notice to members of the Class under the circumstances of this action, (b) was reasonably calculated to apprise members of the Class of the pendency of this action, their right to object to any aspect of the proposed Settlement (including the fairness, reasonableness, or adequacy of the Class’s

' Except as otherwise defined herein, capitalized terms have the meanings afforded them by the Settlement Agreement (ECF No. 88-3).

representation by Class Counsel or their requested award of attorneys’ fees and expenses or the Plan of Allocation), their right to appear at the Final Approval Hearing, and the binding effect of the orders and final judgment as to all claims against Defendants in this action, whether favorable or unfavorable, on all members of the Class, (c) was reasonable and constituted due, adequate, and sufficient notice to all persons entitled to be provided with notice, and (d) fully satisfied the requirements of the Federal Rules of Civil Procedure (including Rules 23(c)(2) and (e)), the United States Constitution, and any other applicable law). 4, Class Action Fairness Act Notice. Based on the submission by Defendants, Defendants have caused to be served a notice of the proposed Settlement on appropriate state and federal officials in accordance with the requirements under the Class Action Fairness Act, 28 U.S.C § 1715(b), and have satisfied their obligations thereundeg, 3. Rule 23 Approval Factors. Each of the factors specified by Rule 23(e)(2) favors final approval. a. Adequacy of Class Representatives. Jackson and Meda fulfilled their duties to the Class by reviewing the pleadings, communicating regularly with Class Counsel, participating in the mediation and post-mediation settlement discussions, and reviewing the proposed Settlement Agreement. ECF No, 87-1 at II.D.1. This factor favors final approval. b. Adequacy of Class Counsel. The Court previously found Class Counsel have extensive experience litigating ERISA class actions. Preliminary Approval Order § 2(d). Additionally, Class Counsel had sufficient information on which to base a settlement, including the necessary data, documents and understanding of the claims and defenses. As such, Class

Counsel have adequately represented the Class. This factor favors final approval. c. Arm’s Length Negotiation. The Court previously found that the Settlement was the result of arms-length negotiations by well-informed and experienced counsel who were aided by a neutral mediator, Robert Meyer with significant experience mediating complex ERISA class actions . Preliminary Approval Order at J 11. The Court reaffirms this finding. This factor favors final approval. d. Relief to the Class. The Settlement provides substantial relief to the Class. Class Counsel calculates that the $7,150,000.00 in monetary relief provided by the Settlement amounts to approximately 41.8% of the maximum amount of losses that Class members could potentially recover at trial (less only court-approved expenses with attorneys’ fees to be decided separately). Preliminary Approval Order at □ 12. The Court previously held that this represented “‘an excellent result compared to other ERISA class settlements approved by other courts of this Circuit.” Jd. (citing among others Baptista v. Mut. of Omaha Ins. Co., 859 F, Supp, 2d 236, 241 (D.R.I. 2012) (approving settlement equivalent to 40% of maximum possible recovery); Hochstadt v. Bos. Sci. Corp., 708 F. Supp. 2d 95, 109 (D. Mass. 2010) (approving 27% recovery in employer stock case as “plainly reasonable”); Toomey v. Demoulas Super Markets, Inc., No. 1:19-cv-11633, Dkt, 95 at 10 (Mar.24, 2021), approved Dkt, 100 (D. Mass. Apr. 7, 2021) (approving settlement that represented approximately

15-20% of alleged losses); Price v. Eaton Vance Corp., No. 18-12098, Dkt. 32 at 12 (May 6, 2019), approved Dkt, 57 (D. Mass. Sept. 24, 2019) (23% alleged losses). “The average gross recovery of more than $89,000 per class member in this Settlement dwarfs the amount recovered by many other approved ERISA class action settlements.” Jd. (citing cases). The Court reaffirms this finding. This factor thus favors final approval. e. Equitable Treatment of Class Members. The Settlement itself does not distinguish between Class Members, and as the Court has previously held no “Class Member or group of Class Members will receive unduly favorable treatment under the terms of the Settlement Agreement.” Preliminary Approval Order at J 13. The allocation of the Net Settlement Fund is to be according to a court-approved Plan of Allocation proposed by Class Counsel, addressed below. Infra 6. This factor favors final approval. 6. Plan of Allocation. A plan for allocating settlement proceeds, like the settlement itself, should be approved if it is fair, reasonable and adequate. Miller, 2022. WL.20583575 (citing Hill v. State St. Corp., CIV.A. 09-12146-GAO, 2015 WL 127728, at *11 (D. Mass. Jan. 8, 2015) (citing cases)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hochstadt v. Boston Scientific Corp.
708 F. Supp. 2d 95 (D. Massachusetts, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Jackson v. Personal Representative of Donald Comb, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jackson-v-personal-representative-of-donald-comb-mad-2025.